Search

Tara L. Martinez

Examiner (ID: 16552, Phone: (571)270-1470 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
704
Issued Applications
357
Pending Applications
113
Abandoned Applications
259

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19343521 [patent_doc_number] => 20240252484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => Methods and Compositions for Treating Vasomotor Symptoms [patent_app_type] => utility [patent_app_number] => 18/461812 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17815 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461812 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/461812
Methods and Compositions for Treating Vasomotor Symptoms Sep 5, 2023 Pending
Array ( [id] => 18902703 [patent_doc_number] => 20240018188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS [patent_app_type] => utility [patent_app_number] => 18/455139 [patent_app_country] => US [patent_app_date] => 2023-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455139 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/455139
COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS Aug 23, 2023 Pending
Array ( [id] => 18902703 [patent_doc_number] => 20240018188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS [patent_app_type] => utility [patent_app_number] => 18/455139 [patent_app_country] => US [patent_app_date] => 2023-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455139 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/455139
COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS Aug 23, 2023 Pending
Array ( [id] => 19316831 [patent_doc_number] => 20240238371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => MATERIALS AND METHODS FOR EXTRACELLULAR VESICLE-ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 18/363416 [patent_app_country] => US [patent_app_date] => 2023-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18363416 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/363416
MATERIALS AND METHODS FOR EXTRACELLULAR VESICLE-ASSOCIATED DISEASES Jul 31, 2023 Abandoned
Array ( [id] => 19808335 [patent_doc_number] => 12239694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Methods and compositions for improved cognition [patent_app_type] => utility [patent_app_number] => 18/215276 [patent_app_country] => US [patent_app_date] => 2023-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 12752 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/215276
Methods and compositions for improved cognition Jun 27, 2023 Issued
Array ( [id] => 18552187 [patent_doc_number] => 20230250196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/298933 [patent_app_country] => US [patent_app_date] => 2023-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298933 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/298933
CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE Apr 10, 2023 Abandoned
Array ( [id] => 18737990 [patent_doc_number] => 20230346893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition [patent_app_type] => utility [patent_app_number] => 18/132517 [patent_app_country] => US [patent_app_date] => 2023-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19024 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132517 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/132517
Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition Apr 9, 2023 Abandoned
Array ( [id] => 18707540 [patent_doc_number] => 20230330116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS [patent_app_type] => utility [patent_app_number] => 18/192696 [patent_app_country] => US [patent_app_date] => 2023-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7429 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192696 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/192696
MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS Mar 29, 2023 Abandoned
Array ( [id] => 18535940 [patent_doc_number] => 20230241026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/173277 [patent_app_country] => US [patent_app_date] => 2023-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173277 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/173277
NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF Feb 22, 2023 Pending
Array ( [id] => 18536069 [patent_doc_number] => 20230241156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHODS OF TREATING DISEASE WITH TERLIPRESSIN [patent_app_type] => utility [patent_app_number] => 18/105293 [patent_app_country] => US [patent_app_date] => 2023-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105293 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/105293
METHODS OF TREATING DISEASE WITH TERLIPRESSIN Feb 2, 2023 Pending
Array ( [id] => 18536069 [patent_doc_number] => 20230241156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHODS OF TREATING DISEASE WITH TERLIPRESSIN [patent_app_type] => utility [patent_app_number] => 18/105293 [patent_app_country] => US [patent_app_date] => 2023-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105293 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/105293
METHODS OF TREATING DISEASE WITH TERLIPRESSIN Feb 2, 2023 Pending
Array ( [id] => 18842685 [patent_doc_number] => 20230405089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => Heparin-Associated Polypeptides and Uses Thereof [patent_app_type] => utility [patent_app_number] => 18/163155 [patent_app_country] => US [patent_app_date] => 2023-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18163155 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/163155
Heparin-Associated Polypeptides and Uses Thereof Jan 31, 2023 Abandoned
Array ( [id] => 18522236 [patent_doc_number] => 20230232884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => NUTRITIONAL FORMULA [patent_app_type] => utility [patent_app_number] => 18/159363 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67279 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159363 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159363
Nutritional formula Jan 24, 2023 Issued
Array ( [id] => 18308047 [patent_doc_number] => 20230111947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES [patent_app_type] => utility [patent_app_number] => 18/063229 [patent_app_country] => US [patent_app_date] => 2022-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063229 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063229
Methods of prophylaxis of coronavirus infection and treatment of coronaviruses Dec 7, 2022 Issued
Array ( [id] => 18412116 [patent_doc_number] => 11666643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-06-06 [patent_title] => Micronutrient combination to reduce blood pressure [patent_app_type] => utility [patent_app_number] => 18/070224 [patent_app_country] => US [patent_app_date] => 2022-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5586 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070224 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/070224
Micronutrient combination to reduce blood pressure Nov 27, 2022 Issued
Array ( [id] => 18509314 [patent_doc_number] => 20230225385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => Micronutrient combination to reduce blood pressure [patent_app_type] => utility [patent_app_number] => 17/994896 [patent_app_country] => US [patent_app_date] => 2022-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6814 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17994896 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/994896
Micronutrient combination to reduce blood pressure Nov 27, 2022 Issued
Array ( [id] => 18434399 [patent_doc_number] => 20230181693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => METHODS OF TREATING INFLAMMATORY SKIN DISORDERS [patent_app_type] => utility [patent_app_number] => 17/969971 [patent_app_country] => US [patent_app_date] => 2022-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/969971
METHODS OF TREATING INFLAMMATORY SKIN DISORDERS Oct 19, 2022 Abandoned
Array ( [id] => 18198171 [patent_doc_number] => 20230051690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING TUMOR-INDUCED IMMUNE SUPPRESSION [patent_app_type] => utility [patent_app_number] => 17/933276 [patent_app_country] => US [patent_app_date] => 2022-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933276 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/933276
COMPOSITIONS AND METHODS FOR INHIBITING TUMOR-INDUCED IMMUNE SUPPRESSION Sep 18, 2022 Abandoned
Array ( [id] => 18311526 [patent_doc_number] => 20230115426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT [patent_app_type] => utility [patent_app_number] => 17/944998 [patent_app_country] => US [patent_app_date] => 2022-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944998 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/944998
PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT Sep 13, 2022 Pending
Array ( [id] => 18537520 [patent_doc_number] => 20230242617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => FIBRONECTIN BASED SCAFFOLD PROTEINS [patent_app_type] => utility [patent_app_number] => 17/889123 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889123 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/889123
FIBRONECTIN BASED SCAFFOLD PROTEINS Aug 15, 2022 Abandoned
Menu